Stephens & Co. Reiterates Overweight on Vericel, Maintains $44 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst George Sellers has reiterated an Overweight rating on Vericel (NASDAQ:VCEL) and maintained a $44 price target.
September 21, 2023 | 3:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Vericel's stock rating has been reiterated as Overweight by Stephens & Co. with a maintained price target of $44.
The reiteration of an Overweight rating by Stephens & Co. indicates a positive outlook for Vericel. The maintained price target of $44 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100